In recent years, the International Committee of Medical Journal Editors (ICMJE) has been striving to make widespread data sharing the norm. In January 2016, the committee published a proposal to … Continue Reading ICMJE announce new data sharing requirements for publication of clinical trial reports
From guide dogs to guard dogs, and from police dogs to search-and-rescue dogs, we are used to our canine friends helping us out in the world of work. But a … Continue Reading Barking up the wrong tree: predatory journals recruit canine to editorial boards
In a position paper published in The Leadership Quarterly earlier this year, Professor John Antonakis described factors that he believes are stifling the production of useful scientific research. In response to … Continue Reading ‘Bad science’ and how new ideas in scientific publishing can combat it
Artificial intelligence (AI) is already being used in scientific publishing for a range of functions: from identifying peer reviewers and detecting plagiarism, to checking for poor reporting, data fabrication and … Continue Reading Is artificial intelligence the future of scientific publishing?
Why does it take so long to submit a manuscript? This is the question posed by Professors Robert Montgomerie and Tim Birkhead in a recent opinion piece in The Scientist. … Continue Reading Professors express their frustration with the manuscript submission process
Many funding organisations now encourage or require researchers to share their datasets in full upon publication, for example by linking to a data repository such as Dryad or Figshare. It … Continue Reading Less than a quarter of top biomedical journals require data sharing
A hot topic in the reporting of clinical research, Medical Publishing Insights and Practices (MPIP) is inviting interested parties to share their perspective and ideas on What Transparency Means to … Continue Reading Join the conversation: what does transparency mean to you?
Approximately 150 pharmaceutical industry professionals, payers and other subject matter experts came together late last month for the eyeforpharma 5th Annual Real World Evidence Europe conference (25–26 April 2017, Amsterdam, … Continue Reading The 5th Annual Real World Evidence Europe Summit 2017: Day 2 meeting report
In a recent post on the BioMed Central blog, postdoctoral researcher Elodie Chabrol describes the frustration she felt upon realising that the slow pace of peer review would potentially delay … Continue Reading A frustrated scientist’s views on peer review
The pharmaceutical industry has previously been accused of failing to submit all clinical trials data for publication, particularly if the results are unfavourable for the drugs in question. However, a … Continue Reading Does submission or publication bias exist in human drug studies?
Josh Brown, of ORCiD describes their vision of a world where all who participate in research, scholarship, and innovation are uniquely identified and connected to their contributions across disciplines, borders, … Continue Reading [VIDEO] An introduction to ORCiD
Ben McLeish of Altmetric explains how this data science company is dedicated to tracking and analyzing the online activity around scholarly research outputs, and how you can use their tools … Continue Reading [VIDEO] Altmetric data, services, and platform: An overview
Caroline Struthers of The EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network describes how this international initiative promotes transparent and accurate reporting and wider use of robust reporting … Continue Reading [VIDEO] The EQUATOR Network: supporting writers to publish high-impact health research
Approximately 150 pharmaceutical industry professionals, payers and other subject matter experts came together late last month for the eyeforpharma 5th Annual Real World Evidence Europe conference (25–26 April 2017, Amsterdam, … Continue Reading The 5th Annual Real World Evidence Europe Summit 2017: Day 1 meeting report
Want to know more about open access publishing models and other innovations in medical publishing? Join Liz Hoffman (Journal Development Manager for the health services research journals at BioMed … Continue Reading [FREE WEBINAR]: publication models and open access
A major international publisher, Springer Nature, has retracted 107 papers after discovering they had been accepted with fake peer reviews. All 524 authors involved are from China. The news has … Continue Reading [VIDEO] Cancer journal retracts 107 Chinese papers over fake peer-reviews